D. McKeith

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, The Lancet.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Esomeprazole 20 mg on‐demand is more acceptable to patients than continuous lansoprazole 15 mg in the long‐term maintenance of endoscopy‐negative gastro‐oesophageal reflux patients: the COMMAND Study

J. Rosen, D. Vearer, D. McKeith, 2004, Alimentary pharmacology & therapeutics.

Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis.

M. Aubier, M. Rangaraju, A. Leak, 2002, Respiratory medicine.

A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis

L. Lohmander, J. Szechiński, C. Ramos-Remus, 2004, Annals of the rheumatic diseases.

AZD3582 versus naproxen in osteoarthritis of the gastrointestinal safety and efficacy of A randomised, placebo controlled, comparative trial

L. Lohmander, J. Szechiński, C. Ramos-Remus, 2005 .

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.